Eloxizumab is effective in lowering blood lipids, and side effects include upper respiratory tract infections and gastroenteritis. The medication should be used according to the doctor’s instructions. Eloxacinumab is a hypolipidemic drug for subcutaneous injection, belonging to the human monoclonal immunoglobulin, which reduces blood LDL cholesterol levels by inhibiting the binding of the circulating human preprotein convertase chytolysin kexin9 to the LDL receptor. Possible side effects of the drug include upper respiratory tract infection, gastroenteritis, nasopharyngitis, local discomfort from injection, headache and dizziness. This drug is contraindicated in allergic persons, and used with caution in pregnant and lactating women. People with high blood lipids need to standardize treatment under the guidance of physicians and pay attention to review. If there is any adverse reaction after the use of the drug need to stop the drug in time to seek medical attention.